can tirzepatide increase liver enzymes 🧠Let's break the drug down using this mnemonic cloud!⁠ ⁠ 💉 Tirzepatide is a GLP-1 and GIP agonist. ⁠ ⁠ 🤔But what exactly is glucagon-like peptide (GLP-1) and gastric inhibitory polypeptide (GIP)? ⁠ ⁠ A Comprehensive Review of Metabolic

GLP-1 medications slow gastric emptying and affect appetite-regulating hormones, which can trigger nausea as a side effect

Potential effects of current drug therapies on cognitive impairment in patients with type 2 diabetes

GLP-1 medications cause sulfur burps and bloating by slowing gastric emptying , which keeps food in the stomach longer and increases pressure and post-meal discomfort, especially after larger or higher-fat meals. Scientific explanation delayed gastric emptying and pyloric tone GLP-1 receptor agonists reduce gastric motility and increase pyloric sphincter tone , delaying the passage of solid food from the stomach into the small intestine

These medications can be valuable options for individuals with diabetes who are looking to improve their cardiovascular health

Most people begin losing weight on semaglutide within 24 weeks, with more noticeable and consistent weight loss typically occurring after 812 weeks, once doses are increased to therapeutic levels

These results suggest that the uptake of GLP-1RAs into the brain via tanycytes is important for their anti-obesity effects